These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15199945)

  • 21. CoMFA and CoMSIA studies on HIV-1 attachment inhibitors.
    Lu P; Wei X; Zhang R
    Eur J Med Chem; 2010 May; 45(5):1792-8. PubMed ID: 20149491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial charge calculation method affects CoMFA QSAR prediction accuracy.
    Mittal RR; Harris L; McKinnon RA; Sorich MJ
    J Chem Inf Model; 2009 Mar; 49(3):704-9. PubMed ID: 19239274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of validated QSAR models of D1 dopaminergic antagonists for database mining.
    Oloff S; Mailman RB; Tropsha A
    J Med Chem; 2005 Nov; 48(23):7322-32. PubMed ID: 16279792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.
    Doddareddy MR; Cho YS; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3D-QSAR CoMFA of a series of DABO derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors.
    de Brito MA; Rodrigues CR; Cirino JJ; de Alencastro RB; Castro HC; Albuquerque MG
    J Chem Inf Model; 2008 Aug; 48(8):1706-15. PubMed ID: 18671385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
    Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
    J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
    Salum Lde B; Polikarpov I; Andricopulo AD
    J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.
    da Cunha EF; Sippl W; de Castro Ramalho T; Ceva Antunes OA; de Alencastro RB; Albuquerque MG
    Eur J Med Chem; 2009 Nov; 44(11):4344-52. PubMed ID: 19616874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative molecular field analysis of a series of paclitaxel analogues.
    Zhu Q; Guo Z; Huang N; Wang M; Chu F
    J Med Chem; 1997 Dec; 40(26):4319-28. PubMed ID: 9435901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA.
    Gueto C; Ruiz JL; Torres JE; Méndez J; Vivas-Reyes R
    Bioorg Med Chem; 2008 Mar; 16(5):2439-47. PubMed ID: 18065233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators.
    Labrie P; Maddaford SP; Fortin S; Rakhit S; Kotra LP; Gaudreault RC
    J Med Chem; 2006 Dec; 49(26):7646-60. PubMed ID: 17181148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D-QSAR of histone deacetylase inhibitors: hydroxamate analogues.
    Juvale DC; Kulkarni VV; Deokar HS; Wagh NK; Padhye SB; Kulkarni VM
    Org Biomol Chem; 2006 Aug; 4(15):2858-68. PubMed ID: 16855733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CoMFA and docking studies of 2-phenylindole derivatives with anticancer activity.
    Liao SY; Qian L; Miao TF; Lu HL; Zheng KC
    Eur J Med Chem; 2009 Jul; 44(7):2822-7. PubMed ID: 19167135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D-QSAR comparative molecular field analysis on delta opioid receptor agonist SNC80 and its analogs.
    Peng Y; Keenan SM; Zhang Q; Welsh WJ
    J Mol Graph Model; 2005 Sep; 24(1):25-33. PubMed ID: 15950508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses of choline acetyltransferase inhibitors.
    Chandrasekaran V; McGaughey GB; Cavallito CJ; Bowen JP
    J Mol Graph Model; 2004 Sep; 23(1):69-76. PubMed ID: 15331055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative molecular field analysis (CoMFA) study using semiempirical, density functional, ab initio methods and pharmacophore derivation using DISCOtech on sigma 1 ligands.
    Jung D; Floyd J; Gund TM
    J Comput Chem; 2004 Aug; 25(11):1385-99. PubMed ID: 15185333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quionolone carboxylic acid derivatives as HIV-1 integrase inhibitors: Docking-based HQSAR and topomer CoMFA analyses.
    Tong J; Zhan P; Wang XS; Wu Y
    J Chemom; 2017 Dec; 31(12):. PubMed ID: 29606793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
    Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
    J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional quantitative structure-activity relationship modeling of gamma-secretase inhibitors using molecular field analysis.
    Sammi T; Silakari O; Ravikumar M
    Chem Biol Drug Des; 2008 Feb; 71(2):155-66. PubMed ID: 18221306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.